Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deciphering spatial genomic heterogeneity at a single cell resolution in multiple myeloma

PROVIDER: PRJNA723584 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR14295400.fastq.gz	Fastqsanger.gz
	SRR14295401.fastq.gz	Fastqsanger.gz
	SRR14295357.fastq.gz	Fastqsanger.gz
	SRR14295358.fastq.gz	Fastqsanger.gz
	SRR14295359.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 66

Similar Datasets

Spatial transcriptomics unveils novel potential disease mechanisms associated with the microenvironment in Multiple Myeloma

Project description:Understanding the spatial organization of the bone marrow (BM) microenvironment at single cell resolution and the niche specific transcriptional regulatory programs remains a challenge. Using formalin-fixed paraffin-embedded (FFPE) samples from our recently described MIcγ1 multiple myeloma (MM) mouse model (Larrayoz et al, Nat Med. 2023), we performed spatial transcriptional profiling of healthy and multiple myeloma BM using the Visium Spatial Gene Expression analysis (10x Genomics). A custom data-analysis framework that combines spatial with single-cell transcriptomic profiles allowed us to identify cell type composition and establish specific cell relations within the bone marrow. As a result, we defined the spatial distribution of transcriptionally heterogenous MM plasma cell (MM-PC) groups. Furthermore, we spatially defined transcriptional programs involved in the pathogenesis of MM within the BM microenvironment that were associated with MM-PC density gradient, such as the spatial location of T cells with effector and exhausted phenotypes. Application of spatial transcriptomics to FFPE human BM biopsies with varying degrees of PC infiltration validated findings from our murine model. The application of spatial transcriptomics to fully mineralized tissues provides a comprehensive spatial overview of the BM microenvironment allowing the identification of deregulated mechanism involved in the pathogenesis of diseases such as MM.

2025-06-09 | GSE269875 | GEO

Ultra-fast and deep spatial proteomic technology enables topographic mapping of human brain tumors

Project description:Spatial proteomics is essential for resolving molecular heterogeneity and tissue microenvironment, yet it remains constrained by trade‑offs among spatial resolution, analytical throughput, and proteome depth. Here we present SMID‑MOSF, an ultra‑trace and rapid sample preparation strategy based on macroporous ordered siliceous foams-assisted single‑pot, miniaturized in‑solution digestion. Coupled with laser capture microdissection-based in situ sampling, SMID-MOSF enables high‑resolution, deep spatial proteomic profiling within a streamlined workflow. SMID‑MOSF identified over 3700 protein groups from single HEK 293T cells and more than 3000 protein groups from 50-μm mouse brain tissue voxels. The method reduces digestion time to 10 minutes, is compatible with high-resolution grid-based sampling formats, and completes within 1.5 hours, enabling scalable spatial analyses. Applied to human oligodendroglioma and brain metastasis tissues, SMID‑MOSF quantified over 4100 protein groups at 50-μm spatial resolution, delineating histopathological regions and mapping tumor heterogeneity. Integration with flow cytometry-derived immune cell proteomic references and spatial deconvolution further revealed distinct immune microenvironmental features between the two tumor types. Together, SMID‑MOSF provides a scalable framework for whole‑tissue spatial proteomics and broadens access to high‑depth in situ proteome analysis.

2026-04-08 | PXD076766 |

Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma

Project description:Multiple myeloma (MM), a plasma cell (PC) malignancy, is the second most common blood cancer. Despite extensive research, disease heterogeneity within and between patients is poorly characterized, hampering efforts for early diagnosis and improved treatments. Here, we apply single cell RNA-seq to study the heterogeneity of 40 individuals along the MM progression spectrum. We define malignant PC at single cell resolution, demonstrating high inter-patient variability that can be explained by expression of known MM drivers and additional putative factors. Within newly diagnosed patients, we identify extensive sub-clonal structures for 10/29 patients. In asymptomatic patients with early disease and in minimal residual disease post-treatment, we detect tumor PC for a subset of the patients, with the same drivers of active myeloma. Single cell analysis of rare circulating tumor cells (CTC) allows detection of malignant PC, which reflect the BM disease. Our work establishes scRNA-seq for dissecting blood malignancies and devising detailed molecular characterization of tumor cells in symptomatic and asymptomatic patients.

2018-12-07 | GSE117156 | GEO

A Xenium Spatial Atlas of Muscle-Invasive Bladder Cancer Reveals Lineage-Specific Vulnerabilities

Project description:Xenium-based spatial transcriptomics was performed to characterize cellular heterogeneity and spatial organization in muscle-invasive bladder cancer (MIBC). Xenium enabled high-resolution in situ mapping of selected gene expression at single-cell resolution in formalin-fixed paraffin-embedded (FFPE) tissue sections. Together, these data provide complementary insights into tumor cell states, lineage programs, and their spatial relationships with the tumor microenvironment, including immune and stromal components. This dataset enables investigation of tumor heterogeneity, lineage plasticity, and spatially resolved cell–cell interactions in MIBC.

2026-05-05 | GSE326226 | GEO

Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

Project description:Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution

| PRJNA511668 | ENA

Deciphering human macrophage development at single-cell resolution

Project description:Deciphering human macrophage development at single-cell resolution

| PRJNA551221 | ENA

Deciphering Primate Retinal Aging at Single-Cell Resolution

Project description:Deciphering Primate Retinal Aging at Single-Cell Resolution

| PRJNA454464 | ENA

A single-cell resolution spatial transcriptomics atlas of human multiple sclerosis lesion (MERSCOPE)

Project description:A single-cell resolution spatial transcriptomics atlas of human multiple sclerosis lesion (MERSCOPE)

| PRJNA1196815 | ENA

All-at-once spatial proteome profiling of complex tissue context with single-cell-type resolution by proximity proteomics

Project description:Spatial proteomics enables in-depth mapping of cellular components and tissue architectures, mostly achieved by laser microdissection-mass spectrometry (LMD-MS) and antibody-based imaging. However, the trade-offs among sampling resolution, throughput, and proteome coverage still limit the applicability of these strategies, especially toward deep proteome profiling with high spatial resolution. Here, we propose PSPro (Proximity labeling for Spatial Proteomics) by leveraging precise antibody-targeted biotinylation at three-dimension scale and efficient affinity purification for MS-based cell-type-specific proteome profiling from single tissue slice. With fine-tuned labeling parameters, PSPro achieves all-at-once cell-type proteome capture with sub-micrometer resolution and shows comparable performance to flow cytometry- and LMD-based proteomic workflows. We apply PSPro to fixed tumor and spleen slices, enriching thousands of proteins containing known markers from ten cell types. For tissue microenvironments with high heterogeneity, we further incorporate region-resolved LMD into PSPro to facilitate direct comparison of cell subpopulations from the same tissue slice, revealing spatial proteome heterogeneity of cancer cells and immune cells in pancreatic tumor. Collectively, PSPro converts traditional “antibody-epitope” paradigm to “antibody-cell type proteome” for spatial biology in a user-friendly manner.

2024-02-02 | MSV000093995 | MassIVE

Bulk RNAseq expression data of colon biopsies from intestinal mucosa of non-IBD controls and patients with Crohn's disease or ulcerative colitis

Project description:Ulcerative colitis and Crohn’s disease are chronic inflammatory intestinal diseases with perplexing heterogeneity in manifestations and response to treatment. While the molecular basis for this heterogeneity remains uncharacterized, single-cell technologies allow us to explore the transcriptional states within tissues at an unprecedented resolution which could further understanding of these complex diseases. Here, we apply single-cell RNA-sequencing to human inflamed intestine and show that the largest differences among patients are present within the myeloid compartment including macrophages and neutrophils. Using spatial transcriptomics in human tissue at single-cell resolution (CosMx Spatial Molecular Imaging) we spatially localized each of the macrophage and neutrophil subsets identified by single-cell RNA-sequencing and unravel further macrophage diversity based on their tissue localization. Finally, single-cell RNA-sequencing combined with single-cell spatial analysis reveals a strong communication network involving macrophages and inflammatory fibroblasts. Our data sheds light on the cellular complexity of these diseases and points towards the myeloid and stromal compartments as important cellular subsets for understanding patient-to-patient heterogeneity.

2023-06-20 | GSE235236 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data